Halozyme Therapeutics Investor Relations Material
Latest events
Q2 2025
Halozyme Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Halozyme Therapeutics Inc
Access all reports
Halozyme Therapeutics Inc is a biotechnology company that develops and licenses drug delivery technology and oncology therapeutics. Its ENHANZE drug delivery platform is used to facilitate the subcutaneous administration of biologics. The company also has proprietary oncology assets under development. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Halozyme Therapeutics Inc
Guidance
Halozyme Therapeutics Inc
Q2 2025
Halozyme Therapeutics Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
HALO
Country
🇺🇸 United States